Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG)
S. Kerpel-Fronius, V. Erdélyi-Tóth, F. Gyergyay, I. Hindy, Z. Mechl, M. Nekulová, S. Somfai-Relle, P. Kovács, Gy. Ujj, B. Kanyar, S. EckhardtVolume:
16
Language:
english
Pages:
5
DOI:
10.1007/bf00293989
Date:
April, 1986
File:
PDF, 563 KB
english, 1986